December 06, 2018
1 min read

FDA clears Bausch + Lomb multifocal toric contact lens

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

Bausch + Lomb announced that it received 510(k) clearance from the FDA for Bausch + Lomb Ultra Multifocal for Astigmatism contact lenses.

According to a company press release, the multifocal toric will be available in a fitting set.

Bausch + Lomb Ultra Multifocal for Astigmatism contact lenses were developed to specifically fulfill a significant unmet need for patients who require astigmatic correction – the second largest segment in contact lenses – and are presbyopic or entering the age of presbyopia,” John Ferris, general manager, U.S. Vision Care, Bausch + Lomb, said in the release. “Up until now, the contact lens options for this group of patients have been limited to custom ordered lenses, monovision, readers or complete contact lens dropout.”

A majority of adults 40 years or older currently wear some type of vision correction, the company said in the release, and one-third of that group is astigmatic. The availability of Bausch + Lomb Ultra Multifocal for Astigmatism contact lenses in a standard fitting set will allow eye care providers to prescribe these lenses during the initial visit.

Bausch + Lomb said these lenses are expected to be available by mid-2019.